Industries > Pharma > Oral Contraceptive Pills Market Report 2021-2031
Oral Contraceptive Pills Market Report 2021-2031
By Type (Combination, Progestin Only, and Others), By Age (15-19, 20-29, 30-39, and 40-49), By Drug Type (Generic Drug, and Branded Drug), By End User (Hospitals, Homecare, Specialty Clinics, Academic and Research Institute, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Leading Regional/ Country market analysis
Oral Contraceptive Pills Market– our new study reveals trends, R&D progress, and predicted revenues
Where the Oral Contraceptive Pills is market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our 210+ page report provides 350+ tables and 330+ charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Oral Contraceptive Pills Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
• Revenue and growth forecasts from 2021 to 2031 for the Global Oral Contraceptive Pills Market By Type
• Combination
o Monophasic
o Triphasic
o Others
• Progestin Only
o Camila
o Errin
o Heather
o Jolivette
o Nora-BE
• Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Oral Contraceptive Pills Market By Age
• 15-19
• 20-29
• 30-39
• 40-49
• Revenue and growth forecasts from 2021 to 2031 for the Global Oral Contraceptive Pills Market By Drug Type
• Generic Drug
• Branded Drug
• Revenue and growth forecasts from 2021 to 2031 for the Global Oral Contraceptive Pills Market by End User
• Hospitals
• Homecare
• Specialty Clinics
• Academic and Research Institute
• Others
• Revenue and growth forecasts from 2021 to 2031 for the Global Oral Contraceptive Pills Market by Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Oral Contraceptive Pills Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Oral Contraceptive Pills Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Oral Contraceptive Pills Market report helps you
In summary, our 210+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Oral Contraceptive Pills Market, with forecasts for Get our report today Oral Contraceptive Pills Market Forecast 2021-2031: By Drug Type, End User, Distribution Channel and Leading Regional/ Country market analysis each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Oral Contraceptive Pills market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Oral Contraceptive Pills Market. Some of the company’s profiled in this report include
• Allergan plc
• Bayer AG
• Johnson & Johnson Services, Inc.
• Mankind Pharma Ltd.
• Merck & Co., Inc.
• Pfizer, Inc.
• Teva Pharmaceutical Industries Ltd.
• Piramal Enterprises
• Syzygy Healthcare LLC
• Cipla Limited
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Oral Contraceptive Pills Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Oral Contraceptive Pills Market Report 2021-2031: By Type (Combination, Progestin Only, and Others), By Age (15-19, 20-29, 30-39, and 40-49), By Drug Type (Generic Drug, and Branded Drug), By End User (Hospitals, Homecare, Specialty Clinics, Academic and Research Institute, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Leading Regional/ Country market analysis . Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Oral Contraceptive Pills Market
2.1. Oral Contraceptive Pills Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Condition Submarkets Definitions
3. Oral Contraceptive Pills Market Overview
3.1. Global Oral Contraceptive Pills Market Size and Forecast By Region
3.2. Global Oral Contraceptive Pills Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing incidence of unintended pregnancies
3.3.1.2. Increasing research and development for oral contraceptive pills
3.3.1.3. Rising awareness regarding treatment of neurological disorder
3.3.1.4. Increasing strategic initiatives in oral contraceptive pills market
3.3.2. Market Restraints
3.3.2.1. Unmet medical needs
3.3.2.2. Stringent regulation
3.3.3. Opportunities
3.3.3.1. Increasing strategic initiatives in oral contraceptive pills market
3.3.3.2. Increasing disposable income in emerging countries
3.3.4. Challenges
3.3.4.1. Availability of alternative methods
3.3.4.2. Side effects associated with the Oral Contraceptive Pills
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Oral Contraceptive Pills Market Analysis and Forecast 2021-2031, By Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Combination
4.1.1.1. Combination market size and forecast, 2021-2031 (USD Million)
4.1.2. Progestin Only
4.1.2.1. Progestin Only market size and forecast, 2021-2031 (USD Million)
4.1.3. Others
4.1.3.1. Others market size and forecast, 2021-2031 (USD Million)
5. Global Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 By Age (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. 15-19
5.1.1.1. 15-19 market size and forecast, 2021-2031 (USD Million)
5.1.2. 20-29
5.1.2.1. 20-29 market size and forecast, 2021-2031 (USD Million)
5.1.3. 30-39
5.1.3.1. 30-39 market size and forecast, 2021-2031 (USD Million)
5.1.4. 40-49
5.1.4.1. 40-49 market size and forecast, 2021-2031 (USD Million)
6. Global Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 By Drug Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Generic Drugs
6.1.1.1. Generic Drugs market size and forecast, 2021-2031 (USD Million)
6.1.2. Branded Drugs
6.1.2.1. Branded Drugs market size and forecast, 2021-2031 (USD Million)
7. Global Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Hospitals
7.1.1.1. Hospitals market size and forecast, 2021-2031 (USD Million)
7.1.2. Homecare
7.1.2.1. Homecare market size and forecast, 2021-2031 (USD Million)
7.1.3. Academic and Research Institute
7.1.3.1. Academic and Research Institute market size and forecast, 2021-2031 (USD Million)
7.1.4. Specialty Clinics
7.1.4.1. Specialty Clinics market size and forecast, 2021-2031 (USD Million)
7.1.5. Others
7.1.5.1. 7.1.5. Others market size and forecast, 2021-2031 (USD Million)
8. Global Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Hospitals Pharmacy
8.1.1.1. Hospitals Pharmacy market size and forecast, 2021-2031 (USD Million)
8.1.2. Retail Pharmacy
8.1.2.1. Retail Pharmacy market size and forecast, 2021-2031 (USD Million)
8.1.3. Online Pharmacies
8.1.3.1. Online Pharmacies market size and forecast, 2021-2031 (USD Million)
9. North America Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. North America Oral Contraceptive Pills Market Size and Forecast By Type
9.2.1.1. XX Driving/Opportunity Factor
9.2.1.2. XX Driving/Opportunity Factor
9.3. North America Oral Contraceptive Pills Market Size and Forecast By Age
9.3.1.1. XX Driving/Opportunity Factor
9.3.1.2. XX Driving/Opportunity Factor
9.4. North America Oral Contraceptive Pills Market Size and Forecast By Drug Type
9.4.1.1. XX Driving/Opportunity Factor
9.4.1.2. XX Driving/Opportunity Factor
9.5. North America Oral Contraceptive Pills Market Size and Forecast By End-User
9.5.1.1. XX Driving/Opportunity Factor
9.5.1.2. XX Driving/Opportunity Factor
9.6. North America Oral Contraceptive Pills Market Size and Forecast By Distribution Channel
9.6.1.1. XX Driving/Opportunity Factor
9.6.1.2. XX Driving/Opportunity Factor
9.7. U.S. Oral Contraceptive Pills Market
9.7.1.1. XX Driving/Opportunity Factor
9.7.1.2. XX Driving/Opportunity Factor
9.8. Canada Oral Contraceptive Pills Market
9.8.1.1. XX Driving/Opportunity Factor
9.8.1.2. XX Driving/Opportunity Factor
10. Europe Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Europe Oral Contraceptive Pills Market Size and Forecast By Type
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. Europe Oral Contraceptive Pills Market Size and Forecast By Age
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. Europe Oral Contraceptive Pills Market Size and Forecast By Drug Type
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. Europe Oral Contraceptive Pills Market Size and Forecast By End-User
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. Europe Oral Contraceptive Pills Market Size and Forecast By Distribution Channel
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. UK Oral Contraceptive Pills Market
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. Germany Oral Contraceptive Pills Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. France Oral Contraceptive Pills Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
10.10. Rest of Europe Oral Contraceptive Pills Market
10.10.1.1. XX Driving/Opportunity Factor
10.10.1.2. XX Driving/Opportunity Factor
11. Asia Pacific Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Asia-Pacific Oral Contraceptive Pills Market Size and Forecast By Type
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Asia-Pacific Oral Contraceptive Pills Market Size and Forecast By Age
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Asia-Pacific Oral Contraceptive Pills Market Size and Forecast By Drug Type
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Asia-Pacific Oral Contraceptive Pills Market Size and Forecast By End-User
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Asia-Pacific Oral Contraceptive Pills Market Size and Forecast By Distribution Channel
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. China Oral Contraceptive Pills Market
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. India Oral Contraceptive Pills Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Japan Oral Contraceptive Pills Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. Rest of Asia Pacific Oral Contraceptive Pills Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
12. Latin America Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Latin America Oral Contraceptive Pills Market Size and Forecast By Type
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Latin America Oral Contraceptive Pills Market Size and Forecast By Age
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Latin America Oral Contraceptive Pills Market Size and Forecast By Drug Type
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Latin America Oral Contraceptive Pills Market Size and Forecast By End-User
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Latin America Oral Contraceptive Pills Market Size and Forecast By Distribution Channel
12.7. Brazil Oral Contraceptive Pills Market
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. Mexico Oral Contraceptive Pills Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. Rest of Latin America Oral Contraceptive Pills Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
13. MEA Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. MEA Oral Contraceptive Pills Market Size and Forecast By Type
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. MEA Oral Contraceptive Pills Market Size and Forecast By Age
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. MEA Oral Contraceptive Pills Market Size and Forecast By Drug Type
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. MEA Oral Contraceptive Pills Market Size and Forecast By End-User
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. MEA Oral Contraceptive Pills Market Size and Forecast By Distribution Channel
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. GCC Oral Contraceptive Pills Market
13.7.1.1. XX Driving/Opportunity Factor
13.7.1.2. XX Driving/Opportunity Factor
13.8. South Africa Oral Contraceptive Pills Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Rest of MEA Oral Contraceptive Pills Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
14. Companies in the Oral Contraceptive Pills Market
14.1. Pfizer Inc
14.1.1. Company Snapshot
14.1.2. Company Overview
14.1.3. Financial Performance (2015-2019)
14.1.3.1. Net Revenue
14.1.3.2. Gross Profit
14.1.3.3. Geographical Revenue, 2019
14.1.4. Product Offerings
14.1.5. Recent Initiatives (2017-2019)
14.2. Merck & Co., Inc. plc
14.2.1. Company Snapshot
14.2.2. Company Overview
14.2.3. Financial Performance (2015-2019)
14.2.3.1. Net Revenue
14.2.3.2. Gross Profit
14.2.3.3. Geographical Revenue, 2019
14.2.4. Product Offerings
14.2.5. Recent Initiatives (2017-2019)
14.3. Bayer AG
14.3.1. Company Snapshot
14.3.2. Company Overview
14.3.3. Financial Performance (2015-2019)
14.3.3.1. Net Revenue
14.3.3.2. Gross Profit
14.3.3.3. Geographical Revenue, 2019
14.3.4. Product Offerings
14.3.5. Recent Initiatives (2017-2019)
14.4. Johnson & Johnson Services, Inc.
14.4.1. Company Snapshot
14.4.2. Company Overview
14.4.3. Financial Performance (2015-2019)
14.4.3.1. Net Revenue
14.4.3.2. Gross Profit
14.4.3.3. Geographical Revenue, 2019
14.4.4. Product Offerings
14.4.5. Recent Initiatives (2017-2019)
14.5. Mankind Pharma Ltd.
14.5.1. Company Snapshot
14.5.2. Company Overview
14.5.3. Financial Performance (2015-2019)
14.5.3.1. Net Revenue
14.5.3.2. Gross Profit
14.5.3.3. Geographical Revenue, 2019
14.5.4. Product Offerings
14.5.5. Recent Initiatives (2017-2019)
14.6. Merck & Co., Inc.
14.6.1. Company Snapshot
14.6.2. Company Overview
14.6.3. Financial Performance (2015-2019)
14.6.3.1. Net Revenue
14.6.3.2. Gross Profit
14.6.3.3. Geographical Revenue, 2019
14.6.4. Product Offerings
14.6.5. Recent Initiatives (2017-2019)
14.7. Teva Pharmaceutical Industries Ltd
14.7.1. Company Snapshot
14.7.2. Company Overview
14.7.3. Financial Performance (2015-2019)
14.7.3.1. Net Revenue
14.7.3.2. Gross Profit
14.7.3.3. Geographical Revenue, 2019
14.7.4. Product Offerings
14.7.5. Recent Initiatives (2017-2019)
14.8. Piramal Enterprises
14.8.1. Company Snapshot
14.8.2. Company Overview
14.8.3. Financial Performance (2015-2019)
14.8.3.1. Net Revenue
14.8.3.2. Gross Profit
14.8.3.3. Geographical Revenue, 2019
14.8.4. Product Offerings
14.8.5. Recent Initiatives (2017-2019)
14.9. Syzygy Healthcare LLC
14.9.1. Company Snapshot
14.9.2. Company Overview
14.9.3. Financial Performance (2015-2019)
14.9.3.1. Net Revenue
14.9.3.2. Gross Profit
14.9.3.3. Geographical Revenue, 2019
14.9.4. Product Offerings
14.9.5. Recent Initiatives (2017-2019)
14.10. Cipla Limited
14.10.1. Company Snapshot
14.10.2. Company Overview
14.10.3. Financial Performance (2015-2019)
14.10.3.1. Net Revenue
14.10.3.2. Gross Profit
14.10.3.3. Geographical Revenue, 2019
14.10.4. Product Offerings
14.10.5. Recent Initiatives (2017-2019)
14.11. Other Notable Players
15. Conclusion
16. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Oral Contraceptive Pills Market Drivers & Restraints 2021
Table 7. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 108. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 113. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 117. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 158. Europe Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Europe Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Europe Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Europe Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 183. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 184. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 185. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 186. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 187. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 188. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 189. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 190. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 191. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 192. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 193. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 194. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 195. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 196. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 197. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 198. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 199. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 200. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 201. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 202. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 203. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 204. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 205. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 206. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 207. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 208. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 209. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 210. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 211. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 212. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 237. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 238. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 239. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 240. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 241. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 242. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 243. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 244. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 245. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 246. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 247. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 248. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 249. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 250. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 251. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 252. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. Middle East Oral Contraceptive Pills Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 268. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 269. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 270. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 271. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 272. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 273. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 274. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 275. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 276. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 277. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 278. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 279. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 280. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 281. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 282. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 283. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 284. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 285. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 286. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 287. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 288. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 289. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 290. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 291. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 292. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 293. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 294. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 295. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 296. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 297. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 298. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 299. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 300. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 301. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 302. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 303. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 304. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 305. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 306. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 307. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 308. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 309. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 310. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 311. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 312. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 313. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 314. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 315. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 316. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 317. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 318. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 319. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 320. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 321. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 322. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 323. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 324. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 325. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 326. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 327. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 328. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 329. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 330. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 331. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 332. Leading 10 Oral Contraceptive Pills Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 333. Pfizer IncProfile 2019 (CEO, HQ, Founded, Website)
Table 334. Pfizer Inc Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 335. Merck & Co., Inc. plc Profile 2019 (CEO, HQ, Founded, Website)
Table 336. Merck & Co., Inc. plc Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 337. Bayer AG Profile 2019 (CEO, HQ, Founded, Website)
Table 338. Bayer AG.Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 339. Johnson & Johnson Services, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 340. Johnson & Johnson Services, Inc. Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 341. Mankind Pharma Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 342. Mankind Pharma Ltd. Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 343. Merck & Co., Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 344. Merck & Co., Inc. Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 345. Teva Pharmaceutical Industries Ltd Profile 2019 (CEO, HQ, Founded, Website)
Table 346. Teva Pharmaceutical Industries Ltd Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 347. Piramal Enterprises Profile 2019 (CEO, HQ, Founded, Website)
Table 348. Piramal Enterprises Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 349. Syzygy Healthcare LLC Profile 2019 (CEO, HQ, Founded, Website)
Table 350. Syzygy Healthcare LLC Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 351. Cipla Limited Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 352. Cipla Limited Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 353. Other Companies Involved in the Oral Contraceptive Pills Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Oral Contraceptive Pills Market Drivers & Restraints 2021
Figure 7. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 79. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 80. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 81. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 82. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 83. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 84. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 85. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 86. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 87. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 88. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 89. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 90. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 91. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 92. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 93. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 94. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 95. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 96. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 97. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 98. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 99. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 100. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 101. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 102. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 103. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 104. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 105. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 106. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 107. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 108. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 109. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 110. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 111. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 112. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 113. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 114. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 115. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 116. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 117. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 118. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 119. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 120. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 121. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 122. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 123. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 124. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 125. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 126. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 127. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 128. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 129. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 130. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 131. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 132. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 133. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 134. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 135. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 136. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 137. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 138. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 139. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 140. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 141. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 142. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 143. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 144. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 145. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 146. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 147. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 148. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 149. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 150. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 151. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 152. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 153. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 154. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 155. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 156. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 157. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 158. Europe Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 159. Europe Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 160. Europe Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 161. Europe Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 162. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 163. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 164. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 165. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 166. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 167. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 168. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 173. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 183. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 184. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 185. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 186. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 187. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 188. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 189. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 190. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 191. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 192. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 193. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 194. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 195. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 196. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 197. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 198. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 199. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 200. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 201. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 202. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 203. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 204. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 205. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 206. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 207. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 208. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 209. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 210. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 211. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 212. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 213. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 214. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 215. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 216. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 217. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 218. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 219. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 220. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 221. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 222. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 223. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 224. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 225. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 226. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 227. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 228. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 229. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 230. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 231. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 232. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 233. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 234. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 235. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 236. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 237. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 238. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 239. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 240. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 241. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 242. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 243. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 244. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 245. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 246. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 247. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 248. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 249. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 250. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 251. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 252. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. Middle East Oral Contraceptive Pills Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 268. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 269. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 270. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 271. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 272. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 273. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 274. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 275. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 276. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 277. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 278. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 279. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 280. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 281. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 282. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 283. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 284. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 285. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 286. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 287. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 288. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 289. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 290. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 291. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 292. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 293. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 294. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 295. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 296. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 297. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 298. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 299. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 300. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 301. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 302. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 303. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 304. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 305. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 306. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 307. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 308. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 309. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 310. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 311. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 312. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 313. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 314. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 315. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 316. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 317. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 318. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 319. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 320. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 321. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 322. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 323. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 324. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 325. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 326. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 327. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 328. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 329. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 330. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 331. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 332. Porter’s Five Force Analysis
Companies Mentioned
1. GlaxoSmithKline PLC
2. Biomarin Pharmaceutical Inc
3. Grifols SA
4. UCB SA
5. Eisai Co Ltd
6. Novo Nordisk A/S
7. Alexion Pharmaceuticals Inc
8. Takeda Pharmaceutical Co Ltd
9. Chugai Pharmaceutical Co Ltd
10. Perrigo Company PLC
11. Astellas Pharma Inc
12. Mitsubishi Tanabe Pharma Corp
13. Johnson & Johnson
14. Shanghai Fosun Pharmaceutical Group Co Ltd
15. Jiangsu Hengrui Medicine Co Ltd
16. Allergan plc
17. Shire PLC
18. Kyowa Hakko Kirin Co Ltd
19. Pfizer Inc
20. Taisho Pharmaceutical Holdings Co Ltd
21. MYL.O
22. Zoetis Inc
23. Bristol-Myers Squibb Co
24. Merck & Co Inc
25. AbbVie Inc
26. Jazz Pharmaceuticals PLC
27. Sumitomo Dainippon Pharma Co Ltd
28. AstraZeneca PLC
29. China Grand Automotive Services Co Ltd
30. Daiichi Sankyo Co Ltd
31. Novartis AG
32. Tasly Pharmaceutical Group Co Ltd
33. CSL Ltd
34. Biogen Inc
35. Orion Oyj
36. Bayer AG
37. CSPC Pharmaceutical Group Ltd
38. Sanofi SA
39. Roche Holding AG
40. Ono Pharmaceutical Co Ltd
41. Beijing Tongrentang Co Ltd
42. Kangmei Pharmaceutical Co Ltd
43. Ipsen SA
44. Abbott Laboratories
45. Shionogi & Co Ltd
46. Eli Lilly and Co
47. Recordati Industria Chimica e Farmaceutica SpA
48. Hikma Pharmaceuticals PLC
49. Teva Pharmaceutical Industries Ltd
50. Merck KGaA
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered By This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Oral Contraceptive Pills Market
2.1. Oral Contraceptive Pills Market Definition
2.2. Application Submarkets Definitions
2.3. Component Submarkets Definitions
2.4. Condition Submarkets Definitions
3. Oral Contraceptive Pills Market Overview
3.1. Global Oral Contraceptive Pills Market Size and Forecast By Region
3.2. Global Oral Contraceptive Pills Market Share By Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing incidence of unintended pregnancies
3.3.1.2. Increasing research and development for oral contraceptive pills
3.3.1.3. Rising awareness regarding treatment of neurological disorder
3.3.1.4. Increasing strategic initiatives in oral contraceptive pills market
3.3.2. Market Restraints
3.3.2.1. Unmet medical needs
3.3.2.2. Stringent regulation
3.3.3. Opportunities
3.3.3.1. Increasing strategic initiatives in oral contraceptive pills market
3.3.3.2. Increasing disposable income in emerging countries
3.3.4. Challenges
3.3.4.1. Availability of alternative methods
3.3.4.2. Side effects associated with the Oral Contraceptive Pills
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.1.1. Strength 1
3.3.5.1.2. Strength 2
3.3.5.1.3. Strength 3
3.3.5.2. Weaknesses
3.3.5.2.1. Weakness 1
3.3.5.2.2. Weakness 2
3.3.5.2.3. Weakness 3
3.3.5.3. Opportunities
3.3.5.3.1. Opportunity 1
3.3.5.3.2. Opportunity 2
3.3.5.3.3. Opportunity 3
3.3.5.4. Threats
3.3.5.4.1. Threat 1
3.3.5.4.2. Threat 2
3.3.5.4.3. Threat 3
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Oral Contraceptive Pills Market Analysis and Forecast 2021-2031, By Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Combination
4.1.1.1. Combination market size and forecast, 2021-2031 (USD Million)
4.1.2. Progestin Only
4.1.2.1. Progestin Only market size and forecast, 2021-2031 (USD Million)
4.1.3. Others
4.1.3.1. Others market size and forecast, 2021-2031 (USD Million)
5. Global Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 By Age (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. 15-19
5.1.1.1. 15-19 market size and forecast, 2021-2031 (USD Million)
5.1.2. 20-29
5.1.2.1. 20-29 market size and forecast, 2021-2031 (USD Million)
5.1.3. 30-39
5.1.3.1. 30-39 market size and forecast, 2021-2031 (USD Million)
5.1.4. 40-49
5.1.4.1. 40-49 market size and forecast, 2021-2031 (USD Million)
6. Global Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 By Drug Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Generic Drugs
6.1.1.1. Generic Drugs market size and forecast, 2021-2031 (USD Million)
6.1.2. Branded Drugs
6.1.2.1. Branded Drugs market size and forecast, 2021-2031 (USD Million)
7. Global Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 By End-User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Hospitals
7.1.1.1. Hospitals market size and forecast, 2021-2031 (USD Million)
7.1.2. Homecare
7.1.2.1. Homecare market size and forecast, 2021-2031 (USD Million)
7.1.3. Academic and Research Institute
7.1.3.1. Academic and Research Institute market size and forecast, 2021-2031 (USD Million)
7.1.4. Specialty Clinics
7.1.4.1. Specialty Clinics market size and forecast, 2021-2031 (USD Million)
7.1.5. Others
7.1.5.1. 7.1.5. Others market size and forecast, 2021-2031 (USD Million)
8. Global Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 By Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.1.1. Hospitals Pharmacy
8.1.1.1. Hospitals Pharmacy market size and forecast, 2021-2031 (USD Million)
8.1.2. Retail Pharmacy
8.1.2.1. Retail Pharmacy market size and forecast, 2021-2031 (USD Million)
8.1.3. Online Pharmacies
8.1.3.1. Online Pharmacies market size and forecast, 2021-2031 (USD Million)
9. North America Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. North America Oral Contraceptive Pills Market Size and Forecast By Type
9.2.1.1. XX Driving/Opportunity Factor
9.2.1.2. XX Driving/Opportunity Factor
9.3. North America Oral Contraceptive Pills Market Size and Forecast By Age
9.3.1.1. XX Driving/Opportunity Factor
9.3.1.2. XX Driving/Opportunity Factor
9.4. North America Oral Contraceptive Pills Market Size and Forecast By Drug Type
9.4.1.1. XX Driving/Opportunity Factor
9.4.1.2. XX Driving/Opportunity Factor
9.5. North America Oral Contraceptive Pills Market Size and Forecast By End-User
9.5.1.1. XX Driving/Opportunity Factor
9.5.1.2. XX Driving/Opportunity Factor
9.6. North America Oral Contraceptive Pills Market Size and Forecast By Distribution Channel
9.6.1.1. XX Driving/Opportunity Factor
9.6.1.2. XX Driving/Opportunity Factor
9.7. U.S. Oral Contraceptive Pills Market
9.7.1.1. XX Driving/Opportunity Factor
9.7.1.2. XX Driving/Opportunity Factor
9.8. Canada Oral Contraceptive Pills Market
9.8.1.1. XX Driving/Opportunity Factor
9.8.1.2. XX Driving/Opportunity Factor
10. Europe Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Europe Oral Contraceptive Pills Market Size and Forecast By Type
10.2.1.1. XX Driving/Opportunity Factor
10.2.1.2. XX Driving/Opportunity Factor
10.3. Europe Oral Contraceptive Pills Market Size and Forecast By Age
10.3.1.1. XX Driving/Opportunity Factor
10.3.1.2. XX Driving/Opportunity Factor
10.4. Europe Oral Contraceptive Pills Market Size and Forecast By Drug Type
10.4.1.1. XX Driving/Opportunity Factor
10.4.1.2. XX Driving/Opportunity Factor
10.5. Europe Oral Contraceptive Pills Market Size and Forecast By End-User
10.5.1.1. XX Driving/Opportunity Factor
10.5.1.2. XX Driving/Opportunity Factor
10.6. Europe Oral Contraceptive Pills Market Size and Forecast By Distribution Channel
10.6.1.1. XX Driving/Opportunity Factor
10.6.1.2. XX Driving/Opportunity Factor
10.7. UK Oral Contraceptive Pills Market
10.7.1.1. XX Driving/Opportunity Factor
10.7.1.2. XX Driving/Opportunity Factor
10.8. Germany Oral Contraceptive Pills Market
10.8.1.1. XX Driving/Opportunity Factor
10.8.1.2. XX Driving/Opportunity Factor
10.9. France Oral Contraceptive Pills Market
10.9.1.1. XX Driving/Opportunity Factor
10.9.1.2. XX Driving/Opportunity Factor
10.10. Rest of Europe Oral Contraceptive Pills Market
10.10.1.1. XX Driving/Opportunity Factor
10.10.1.2. XX Driving/Opportunity Factor
11. Asia Pacific Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Asia-Pacific Oral Contraceptive Pills Market Size and Forecast By Type
11.2.1.1. XX Driving/Opportunity Factor
11.2.1.2. XX Driving/Opportunity Factor
11.3. Asia-Pacific Oral Contraceptive Pills Market Size and Forecast By Age
11.3.1.1. XX Driving/Opportunity Factor
11.3.1.2. XX Driving/Opportunity Factor
11.4. Asia-Pacific Oral Contraceptive Pills Market Size and Forecast By Drug Type
11.4.1.1. XX Driving/Opportunity Factor
11.4.1.2. XX Driving/Opportunity Factor
11.5. Asia-Pacific Oral Contraceptive Pills Market Size and Forecast By End-User
11.5.1.1. XX Driving/Opportunity Factor
11.5.1.2. XX Driving/Opportunity Factor
11.6. Asia-Pacific Oral Contraceptive Pills Market Size and Forecast By Distribution Channel
11.6.1.1. XX Driving/Opportunity Factor
11.6.1.2. XX Driving/Opportunity Factor
11.7. China Oral Contraceptive Pills Market
11.7.1.1. XX Driving/Opportunity Factor
11.7.1.2. XX Driving/Opportunity Factor
11.8. India Oral Contraceptive Pills Market
11.8.1.1. XX Driving/Opportunity Factor
11.8.1.2. XX Driving/Opportunity Factor
11.9. Japan Oral Contraceptive Pills Market
11.9.1.1. XX Driving/Opportunity Factor
11.9.1.2. XX Driving/Opportunity Factor
11.10. Rest of Asia Pacific Oral Contraceptive Pills Market
11.10.1.1. XX Driving/Opportunity Factor
11.10.1.2. XX Driving/Opportunity Factor
12. Latin America Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Latin America Oral Contraceptive Pills Market Size and Forecast By Type
12.2.1.1. XX Driving/Opportunity Factor
12.2.1.2. XX Driving/Opportunity Factor
12.3. Latin America Oral Contraceptive Pills Market Size and Forecast By Age
12.3.1.1. XX Driving/Opportunity Factor
12.3.1.2. XX Driving/Opportunity Factor
12.4. Latin America Oral Contraceptive Pills Market Size and Forecast By Drug Type
12.4.1.1. XX Driving/Opportunity Factor
12.4.1.2. XX Driving/Opportunity Factor
12.5. Latin America Oral Contraceptive Pills Market Size and Forecast By End-User
12.5.1.1. XX Driving/Opportunity Factor
12.5.1.2. XX Driving/Opportunity Factor
12.6. Latin America Oral Contraceptive Pills Market Size and Forecast By Distribution Channel
12.7. Brazil Oral Contraceptive Pills Market
12.7.1.1. XX Driving/Opportunity Factor
12.7.1.2. XX Driving/Opportunity Factor
12.8. Mexico Oral Contraceptive Pills Market
12.8.1.1. XX Driving/Opportunity Factor
12.8.1.2. XX Driving/Opportunity Factor
12.9. Rest of Latin America Oral Contraceptive Pills Market
12.9.1.1. XX Driving/Opportunity Factor
12.9.1.2. XX Driving/Opportunity Factor
13. MEA Oral Contraceptive Pills Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
13.1. Market Overview
13.2. MEA Oral Contraceptive Pills Market Size and Forecast By Type
13.2.1.1. XX Driving/Opportunity Factor
13.2.1.2. XX Driving/Opportunity Factor
13.3. MEA Oral Contraceptive Pills Market Size and Forecast By Age
13.3.1.1. XX Driving/Opportunity Factor
13.3.1.2. XX Driving/Opportunity Factor
13.4. MEA Oral Contraceptive Pills Market Size and Forecast By Drug Type
13.4.1.1. XX Driving/Opportunity Factor
13.4.1.2. XX Driving/Opportunity Factor
13.5. MEA Oral Contraceptive Pills Market Size and Forecast By End-User
13.5.1.1. XX Driving/Opportunity Factor
13.5.1.2. XX Driving/Opportunity Factor
13.6. MEA Oral Contraceptive Pills Market Size and Forecast By Distribution Channel
13.6.1.1. XX Driving/Opportunity Factor
13.6.1.2. XX Driving/Opportunity Factor
13.7. GCC Oral Contraceptive Pills Market
13.7.1.1. XX Driving/Opportunity Factor
13.7.1.2. XX Driving/Opportunity Factor
13.8. South Africa Oral Contraceptive Pills Market
13.8.1.1. XX Driving/Opportunity Factor
13.8.1.2. XX Driving/Opportunity Factor
13.9. Rest of MEA Oral Contraceptive Pills Market
13.9.1.1. XX Driving/Opportunity Factor
13.9.1.2. XX Driving/Opportunity Factor
14. Companies in the Oral Contraceptive Pills Market
14.1. Pfizer Inc
14.1.1. Company Snapshot
14.1.2. Company Overview
14.1.3. Financial Performance (2015-2019)
14.1.3.1. Net Revenue
14.1.3.2. Gross Profit
14.1.3.3. Geographical Revenue, 2019
14.1.4. Product Offerings
14.1.5. Recent Initiatives (2017-2019)
14.2. Merck & Co., Inc. plc
14.2.1. Company Snapshot
14.2.2. Company Overview
14.2.3. Financial Performance (2015-2019)
14.2.3.1. Net Revenue
14.2.3.2. Gross Profit
14.2.3.3. Geographical Revenue, 2019
14.2.4. Product Offerings
14.2.5. Recent Initiatives (2017-2019)
14.3. Bayer AG
14.3.1. Company Snapshot
14.3.2. Company Overview
14.3.3. Financial Performance (2015-2019)
14.3.3.1. Net Revenue
14.3.3.2. Gross Profit
14.3.3.3. Geographical Revenue, 2019
14.3.4. Product Offerings
14.3.5. Recent Initiatives (2017-2019)
14.4. Johnson & Johnson Services, Inc.
14.4.1. Company Snapshot
14.4.2. Company Overview
14.4.3. Financial Performance (2015-2019)
14.4.3.1. Net Revenue
14.4.3.2. Gross Profit
14.4.3.3. Geographical Revenue, 2019
14.4.4. Product Offerings
14.4.5. Recent Initiatives (2017-2019)
14.5. Mankind Pharma Ltd.
14.5.1. Company Snapshot
14.5.2. Company Overview
14.5.3. Financial Performance (2015-2019)
14.5.3.1. Net Revenue
14.5.3.2. Gross Profit
14.5.3.3. Geographical Revenue, 2019
14.5.4. Product Offerings
14.5.5. Recent Initiatives (2017-2019)
14.6. Merck & Co., Inc.
14.6.1. Company Snapshot
14.6.2. Company Overview
14.6.3. Financial Performance (2015-2019)
14.6.3.1. Net Revenue
14.6.3.2. Gross Profit
14.6.3.3. Geographical Revenue, 2019
14.6.4. Product Offerings
14.6.5. Recent Initiatives (2017-2019)
14.7. Teva Pharmaceutical Industries Ltd
14.7.1. Company Snapshot
14.7.2. Company Overview
14.7.3. Financial Performance (2015-2019)
14.7.3.1. Net Revenue
14.7.3.2. Gross Profit
14.7.3.3. Geographical Revenue, 2019
14.7.4. Product Offerings
14.7.5. Recent Initiatives (2017-2019)
14.8. Piramal Enterprises
14.8.1. Company Snapshot
14.8.2. Company Overview
14.8.3. Financial Performance (2015-2019)
14.8.3.1. Net Revenue
14.8.3.2. Gross Profit
14.8.3.3. Geographical Revenue, 2019
14.8.4. Product Offerings
14.8.5. Recent Initiatives (2017-2019)
14.9. Syzygy Healthcare LLC
14.9.1. Company Snapshot
14.9.2. Company Overview
14.9.3. Financial Performance (2015-2019)
14.9.3.1. Net Revenue
14.9.3.2. Gross Profit
14.9.3.3. Geographical Revenue, 2019
14.9.4. Product Offerings
14.9.5. Recent Initiatives (2017-2019)
14.10. Cipla Limited
14.10.1. Company Snapshot
14.10.2. Company Overview
14.10.3. Financial Performance (2015-2019)
14.10.3.1. Net Revenue
14.10.3.2. Gross Profit
14.10.3.3. Geographical Revenue, 2019
14.10.4. Product Offerings
14.10.5. Recent Initiatives (2017-2019)
14.11. Other Notable Players
15. Conclusion
16. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Oral Contraceptive Pills Market Drivers & Restraints 2021
Table 7. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 108. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 113. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 117. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Table 158. Europe Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Europe Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Europe Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Europe Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 183. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 184. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 185. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 186. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 187. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 188. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 189. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 190. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 191. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 192. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 193. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 194. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 195. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 196. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 197. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 198. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 199. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 200. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 201. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 202. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 203. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 204. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 205. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 206. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 207. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 208. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 209. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 210. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 211. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 212. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 237. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 238. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 239. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 240. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 241. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 242. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 243. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 244. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 245. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 246. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 247. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 248. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 249. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 250. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 251. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 252. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 253. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 254. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 255. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 256. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 257. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 258. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 259. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 260. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 261. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 262. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 263. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 264. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 265. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 266. Middle East Oral Contraceptive Pills Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 267. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 268. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 269. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 270. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 271. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 272. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 273. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 274. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 275. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 276. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 277. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 278. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 279. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 280. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 281. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 282. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 283. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 284. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 285. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 286. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 287. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 288. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 289. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 290. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 291. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 292. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 293. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 294. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 295. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 296. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 297. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 298. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 299. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 300. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 301. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 302. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 303. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 304. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 305. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 306. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 307. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 308. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 309. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 310. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 311. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 312. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 313. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 314. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 315. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 316. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 317. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 318. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 319. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 320. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 321. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 322. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 323. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 324. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 325. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 326. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 327. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 328. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 329. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 330. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 331. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 332. Leading 10 Oral Contraceptive Pills Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 333. Pfizer IncProfile 2019 (CEO, HQ, Founded, Website)
Table 334. Pfizer Inc Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 335. Merck & Co., Inc. plc Profile 2019 (CEO, HQ, Founded, Website)
Table 336. Merck & Co., Inc. plc Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 337. Bayer AG Profile 2019 (CEO, HQ, Founded, Website)
Table 338. Bayer AG.Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 339. Johnson & Johnson Services, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 340. Johnson & Johnson Services, Inc. Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 341. Mankind Pharma Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 342. Mankind Pharma Ltd. Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 343. Merck & Co., Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 344. Merck & Co., Inc. Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 345. Teva Pharmaceutical Industries Ltd Profile 2019 (CEO, HQ, Founded, Website)
Table 346. Teva Pharmaceutical Industries Ltd Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 347. Piramal Enterprises Profile 2019 (CEO, HQ, Founded, Website)
Table 348. Piramal Enterprises Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 349. Syzygy Healthcare LLC Profile 2019 (CEO, HQ, Founded, Website)
Table 350. Syzygy Healthcare LLC Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 351. Cipla Limited Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 352. Cipla Limited Oral Contraceptive Pills Product Offering (Segment, Product Offerings)
Table 353. Other Companies Involved in the Oral Contraceptive Pills Market 2021 (Company, Location)
LIST OF FIGURES
Figure 1. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 2. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 3. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 4. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 5. Oral Contraceptive Pills Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 6. Oral Contraceptive Pills Market Drivers & Restraints 2021
Figure 7. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 8. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 9. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 10. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 11. Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 12. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 13. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 14. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 15. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 16. Combination Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 17. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 18. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 19. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 20. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 21. Progestin Only Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 22. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 23. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 24. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 25. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 26. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 27. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 28. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 29. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 30. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 31. Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 32. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 33. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 34. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 35. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 36. 15-19 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 37. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 38. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 39. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 40. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 41. 20-29 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 42. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 43. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 44. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 45. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 46. 30-39 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 47. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 48. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 49. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 50. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 51. 40-49 Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 52. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 53. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 54. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 55. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 56. Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 57. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 58. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 59. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 60. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 61. Generic Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 62. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 63. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 64. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 65. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 66. Branded Drugs Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 67. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 68. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 69. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 70. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 71. Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 72. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 73. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 74. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 75. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 76. Hospitals Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 77. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 78. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 79. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 80. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 81. Homecare Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 82. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 83. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 84. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 85. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 86. Specialty Clinics Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 87. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 88. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 89. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 90. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 91. Academic and Research Institute Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 92. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 93. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 94. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 95. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 96. Others Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 97. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 98. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 99. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 100. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 101. Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 102. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 103. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 104. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 105. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 106. Hospital Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 107. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 108. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 109. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 110. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 111. Retail Pharmacy Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 112. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 113. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 114. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 115. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 116. Online Pharmacies Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 117. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 118. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 119. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 120. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 121. North America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 122. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 123. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 124. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 125. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 126. North America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 127. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 128. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 129. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 130. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 131. North America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 132. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 133. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 134. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 135. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 136. North America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 137. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 138. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 139. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 140. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 141. North America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 142. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 143. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 144. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 145. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 146. North America Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 147. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 148. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 149. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 150. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 151. US Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 152. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 153. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 154. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 155. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 156. Canada Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 157. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID) Table 82.
Figure 158. Europe Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 159. Europe Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 160. Europe Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 161. Europe Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 162. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 163. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 164. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 165. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 166. Europe Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 167. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 168. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 169. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 170. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 171. Europe Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 172. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 173. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 174. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 175. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 176. Europe Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 177. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 178. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 179. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 180. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 181. Europe Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 182. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 183. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 184. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 185. Europe Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 186. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 187. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 188. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 189. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 190. UK Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 191. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 192. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 193. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 194. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 195. Germany Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 196. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 197. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 198. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 199. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 200. France Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 201. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 202. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 203. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 204. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 205. Rest of Europe Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 206. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 207. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 208. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 209. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 210. Asia Pacific Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 211. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 212. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 213. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 214. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 215. Asia Pacific Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 216. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 217. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 218. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 219. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 220. Asia Pacific Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 221. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 222. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 223. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 224. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 225. Asia Pacific Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 226. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 227. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 228. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 229. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 230. Asia Pacific Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 231. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 232. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 233. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 234. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 235. Asia Pacific Oral Contraceptive Pills Market Forecast By Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 236. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 237. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 238. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 239. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 240. China Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 241. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 242. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 243. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 244. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 245. India Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 246. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 247. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 248. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 249. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 250. Japan Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 251. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 252. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 253. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 254. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 255. RoAPAC Oral Contraceptive Pills Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 256. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 257. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 258. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 259. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 260. Middle East Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 261. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 262. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 263. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 264. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 265. Middle East Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 266. Middle East Oral Contraceptive Pills Market Forecast By Patient Demographics 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 267. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 268. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 269. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 270. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 271. Middle East Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 272. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 273. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 274. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 275. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 276. Middle East Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 277. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 278. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 279. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 280. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 281. Middle East Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 282. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 283. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 284. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 285. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 286. Latin America Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 287. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 288. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 289. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 290. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 291. Latin America Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 292. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 293. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 294. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 295. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 296. Latin America Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 297. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 298. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 299. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 300. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 301. Latin America Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 302. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 303. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 304. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 305. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 306. Latin America Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 307. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 308. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 309. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 310. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 311. Africa Oral Contraceptive Pills Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 312. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 313. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 314. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 315. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 316. Africa Oral Contraceptive Pills Market Forecast By Age 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 317. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 318. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 319. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 320. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 321. Africa Oral Contraceptive Pills Market Forecast By Drug Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 322. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 323. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 324. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 325. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 326. Africa Oral Contraceptive Pills Market Forecast By End-User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 327. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 328. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 329. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 330. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 331. Africa Oral Contraceptive Pills Market Forecast By Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 332. Porter’s Five Force Analysis
Companies Mentioned
1. GlaxoSmithKline PLC
2. Biomarin Pharmaceutical Inc
3. Grifols SA
4. UCB SA
5. Eisai Co Ltd
6. Novo Nordisk A/S
7. Alexion Pharmaceuticals Inc
8. Takeda Pharmaceutical Co Ltd
9. Chugai Pharmaceutical Co Ltd
10. Perrigo Company PLC
11. Astellas Pharma Inc
12. Mitsubishi Tanabe Pharma Corp
13. Johnson & Johnson
14. Shanghai Fosun Pharmaceutical Group Co Ltd
15. Jiangsu Hengrui Medicine Co Ltd
16. Allergan plc
17. Shire PLC
18. Kyowa Hakko Kirin Co Ltd
19. Pfizer Inc
20. Taisho Pharmaceutical Holdings Co Ltd
21. MYL.O
22. Zoetis Inc
23. Bristol-Myers Squibb Co
24. Merck & Co Inc
25. AbbVie Inc
26. Jazz Pharmaceuticals PLC
27. Sumitomo Dainippon Pharma Co Ltd
28. AstraZeneca PLC
29. China Grand Automotive Services Co Ltd
30. Daiichi Sankyo Co Ltd
31. Novartis AG
32. Tasly Pharmaceutical Group Co Ltd
33. CSL Ltd
34. Biogen Inc
35. Orion Oyj
36. Bayer AG
37. CSPC Pharmaceutical Group Ltd
38. Sanofi SA
39. Roche Holding AG
40. Ono Pharmaceutical Co Ltd
41. Beijing Tongrentang Co Ltd
42. Kangmei Pharmaceutical Co Ltd
43. Ipsen SA
44. Abbott Laboratories
45. Shionogi & Co Ltd
46. Eli Lilly and Co
47. Recordati Industria Chimica e Farmaceutica SpA
48. Hikma Pharmaceuticals PLC
49. Teva Pharmaceutical Industries Ltd
50. Merck KGaA
Companies Profiled in the Report
1. Allergan plc
2. Bayer AG
3. Johnson & Johnson Services, Inc.
4. Mankind Pharma Ltd.
5. Merck & Co., Inc.
6. Pfizer, Inc.
7. Teva Pharmaceutical Industries Ltd.
8. Piramal Enterprises
9. Syzygy Healthcare LLC
10. Cipla Limited
List of Companies Mentioned in the Report:
1. GlaxoSmithKline PLC
2. Biomarin Pharmaceutical Inc
3. Grifols SA
4. UCB SA
5. Eisai Co Ltd
6. Novo Nordisk A/S
7. Alexion Pharmaceuticals Inc
8. Takeda Pharmaceutical Co Ltd
9. Chugai Pharmaceutical Co Ltd
10. Perrigo Company PLC
11. Astellas Pharma Inc
12. Mitsubishi Tanabe Pharma Corp
13. Johnson & Johnson
14. Shanghai Fosun Pharmaceutical Group Co Ltd
15. Jiangsu Hengrui Medicine Co Ltd
16. Allergan plc
17. Shire PLC
18. Kyowa Hakko Kirin Co Ltd
19. Pfizer Inc
20. Taisho Pharmaceutical Holdings Co Ltd
21. MYL.O
22. Zoetis Inc
23. Bristol-Myers Squibb Co
24. Merck & Co Inc
25. AbbVie Inc
26. Jazz Pharmaceuticals PLC
27. Sumitomo Dainippon Pharma Co Ltd
28. AstraZeneca PLC
29. China Grand Automotive Services Co Ltd
30. Daiichi Sankyo Co Ltd
31. Novartis AG
32. Tasly Pharmaceutical Group Co Ltd
33. CSL Ltd
34. Biogen Inc
35. Orion Oyj
36. Bayer AG
37. CSPC Pharmaceutical Group Ltd
38. Sanofi SA
39. Roche Holding AG
40. Ono Pharmaceutical Co Ltd
41. Beijing Tongrentang Co Ltd
42. Kangmei Pharmaceutical Co Ltd
43. Ipsen SA
44. Abbott Laboratories
45. Shionogi & Co Ltd
46. Eli Lilly and Co
47. Recordati Industria Chimica e Farmaceutica SpA
48. Hikma Pharmaceuticals PLC
49. Teva Pharmaceutical Industries Ltd
50. Merck KGaA
List of Organizations Mentioned in the Report:
1. European Medicines Agency (EMA)
2. Food and Drug Administration (FDA)
3. National Institutes of Health (NIH)
4. United Nations (UN)
5. United Nations Office on Drugs and Crime (UNODC)
6. United Nations Statistics Division (UNSD)
7. Statistical Office of the European Union (EUROSTAT)
8. University of Connecticut
9. World Health Organization (WHO)
10. The National Medical Products Administration (NMPA)
11. Indian Council of Medical Research (ICMR)
12. Medicines and Healthcare Products Regulatory Agency (MHRA)
13. Centre for Pharmaceutical Administration Health Sciences Authority
14. Central Drug Standard Control Organization (CDSCO)
15. Organisation for Economic Co-operation and Development (OECD)
1. Allergan plc
2. Bayer AG
3. Johnson & Johnson Services, Inc.
4. Mankind Pharma Ltd.
5. Merck & Co., Inc.
6. Pfizer, Inc.
7. Teva Pharmaceutical Industries Ltd.
8. Piramal Enterprises
9. Syzygy Healthcare LLC
10. Cipla Limited
List of Companies Mentioned in the Report:
1. GlaxoSmithKline PLC
2. Biomarin Pharmaceutical Inc
3. Grifols SA
4. UCB SA
5. Eisai Co Ltd
6. Novo Nordisk A/S
7. Alexion Pharmaceuticals Inc
8. Takeda Pharmaceutical Co Ltd
9. Chugai Pharmaceutical Co Ltd
10. Perrigo Company PLC
11. Astellas Pharma Inc
12. Mitsubishi Tanabe Pharma Corp
13. Johnson & Johnson
14. Shanghai Fosun Pharmaceutical Group Co Ltd
15. Jiangsu Hengrui Medicine Co Ltd
16. Allergan plc
17. Shire PLC
18. Kyowa Hakko Kirin Co Ltd
19. Pfizer Inc
20. Taisho Pharmaceutical Holdings Co Ltd
21. MYL.O
22. Zoetis Inc
23. Bristol-Myers Squibb Co
24. Merck & Co Inc
25. AbbVie Inc
26. Jazz Pharmaceuticals PLC
27. Sumitomo Dainippon Pharma Co Ltd
28. AstraZeneca PLC
29. China Grand Automotive Services Co Ltd
30. Daiichi Sankyo Co Ltd
31. Novartis AG
32. Tasly Pharmaceutical Group Co Ltd
33. CSL Ltd
34. Biogen Inc
35. Orion Oyj
36. Bayer AG
37. CSPC Pharmaceutical Group Ltd
38. Sanofi SA
39. Roche Holding AG
40. Ono Pharmaceutical Co Ltd
41. Beijing Tongrentang Co Ltd
42. Kangmei Pharmaceutical Co Ltd
43. Ipsen SA
44. Abbott Laboratories
45. Shionogi & Co Ltd
46. Eli Lilly and Co
47. Recordati Industria Chimica e Farmaceutica SpA
48. Hikma Pharmaceuticals PLC
49. Teva Pharmaceutical Industries Ltd
50. Merck KGaA
List of Organizations Mentioned in the Report:
1. European Medicines Agency (EMA)
2. Food and Drug Administration (FDA)
3. National Institutes of Health (NIH)
4. United Nations (UN)
5. United Nations Office on Drugs and Crime (UNODC)
6. United Nations Statistics Division (UNSD)
7. Statistical Office of the European Union (EUROSTAT)
8. University of Connecticut
9. World Health Organization (WHO)
10. The National Medical Products Administration (NMPA)
11. Indian Council of Medical Research (ICMR)
12. Medicines and Healthcare Products Regulatory Agency (MHRA)
13. Centre for Pharmaceutical Administration Health Sciences Authority
14. Central Drug Standard Control Organization (CDSCO)
15. Organisation for Economic Co-operation and Development (OECD)
Download sample pages
Complete the form below to download your free sample pages for Oral Contraceptive Pills Market Report 2021-2031Download sample pages
Complete the form below to download your free sample pages for Oral Contraceptive Pills Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Biologics Market Report 2024-2034
The biologics market is estimated at US$447 billion in 2023 and is projected to grow at a CAGR of 8.5% during the forecast period 2024-2034.
20 November 2023
Visiongain Publishes mRNA Vaccines Market Report 2023-2033
The global mRNA Vaccines market is estimated at US$11,773.3 million in 2023 and is projected to grow at a CAGR of 10.5% during the forecast period 2023-2033.
08 November 2023
Visiongain Publishes Stem Cell Technologies and Applications Market Report 2023-2033
The global Stem Cell Technologies and Applications market is estimated at US$10,059.6 million in 2023 and is projected to grow at a CAGR of 8.7% during the forecast period 2023-2033.
06 November 2023
Visiongain Publishes Neurology Clinical Trials Market Report 2023-2033
The global Neurology Clinical Trials market is valued at US$9,609.2 million in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period 2023-2033.
01 November 2023
